Purchase Order 75N91021P00613

This is a firm fixed-price purchase order awarded by the U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS) Midwest Area to Envigo Bioproducts Inc. for $22,655.00. The contract is for hybridoma services across three stages: Stage 1 - hybridoma services for 3 immunogens and 10 Balb/C mice; Stage 2 - fusion and subcloning services (option); and Stage 3 - cloning and small-scale antibody production (option). The contract has an ultimate completion date of May 31, 2025. Envigo...

This federal contract award is for the purification of the antibody 3H5.1 (ATCC CAT.# HB-46) cell line. The contract, valued at $3,011.00, was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Child Health and Human Development to Biovest International, Inc. on April 3, 2013. The contract is a firm fixed-price purchase order with an expected completion date of April 20, 2013. The place of performance is Bethesda, MD 20892, USA....

This is a $112,658 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI) to Creative Biolabs Inc., a biotechnology and pharmaceutical services company located in Shirley, New York. The contract is for specialized nanobody affinity maturation services using phage display library construction and selection, specifically targeting an anti-human BCMA nanobody for multiple myeloma applications. The objective is to deliver five affinity-optimized nanobody sequences...

This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the prime contractor Aldevron, L.L.C., a for-profit limited liability company that manufactures biologics. The contract is for the production and purification of custom DNA plasmids, specifically 600 mg of pM766 gp160 V1, 40 mg of pSW M766 gp120 V1, and 600 mg of SIV p57 Gag custom plasmids, to support ongoing research...

This firm fixed price purchase order was awarded by the National Institutes of Health National Cancer Institute to Genscript USA Inc. for $30,280. The contract is for the acquisition of recombinant antibody against mouse ErbB2 (HER2) domain IV via custom protein production services. Specifically, Genscript will immunize rabbits with the antigen protein, collect B cell clones to screen for binding to mouse HER2, collect supernatants from 20 antibody clones, and produce and purify the...

The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $40,505 firm-fixed-price purchase order to Charles River Laboratories, Inc. to perform characterization testing of Pichia master and working cell banks. This work supports ongoing research at the Laboratory of Malaria Immunology and Vaccinology to develop a malaria transmission-blocking vaccine candidate. The testing will demonstrate the identity, purity,...

This is a $5,544 firm-fixed-price delivery order contract awarded to Charles River Laboratories, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) for the manufacture and safety testing of experimental virus vaccines. The contract has no set-aside designation. Charles River Laboratories is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development efforts,...

The Centers for Disease Control and Prevention awarded Abcellera Biologics Inc. a definitive fixed price contract valued at $884,000 to provide a transgenic mouse model capable of generating humanized antibodies against influenza viruses. The original solicitation sought proposals for a mouse engineered with human immunoglobulin gene segments to better recapitulate the human antibody repertoire when testing candidate virus strains and developing antibodies. Under the contract, Abcellera will...

This federal contract award, valued at $98,077.50, was issued by the National Cancer Institute (NCI), an agency within the U.S. Department of Health and Human Services, to Sartorius Stedim North America Inc. The contract is for the purchase of CellGenix GMP rh IL-4 50ug vials to support cancer vaccine research and clinical trials conducted by the NCI's Center for Cancer Research, Vaccine Branch. This is a firm fixed-price purchase order contract with a completion date of September 30, 2022....

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a biotechnology company, for "EXPRESS PLASMID PREPARATION, EXPRESS MUTAGENESIS TARGET AND CLONEARK PLASMID PREPARATION" services. The $149,984.10 contract has a completion date of September 13, 2022 and does not have a set-aside designation. Genscript has provided similar services to support...